Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-κB activation in J774 macrophages

FEBS Letters

Volumn 440, Issue 1-2, 1998, Pages 76-80

  D'Acquisto, Fulvio ^a   Sautebin, Lidia ^a   Iuvone, Teresa ^a   Di Rosa, Massimo ^a   Carnuccio, Rosa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Inducible nitric oxide synthase; Lipopolysaccharide; Nuclear factor B; Prostaglandin

Indexed keywords

CYCLIC AMP; ILOPROST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CYTOSOL; DINOPROSTONE; DNA PROBES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; ILOPROST; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; TRANSCRIPTION FACTOR RELA;

EID: 0032573408     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01407-0     Document Type: Article

References (25)

1. [1] Xie, W., Robertson, D.L. and Simmons, D.L. (1992) Drug Dev. Res. 25, 249-265.
2. [2] Lee, S.H., Soyoola, E., Chanmugarn, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D. and Hwang, D. (1992) J. Biol. Chem. 267, 25934-25939.
3. [3] Maier, J.A.M., Hla, T. and Machag, T. (1990) J. Biol. Chem. 265, 10805-10809.
4. [4] Marotta, P., Sautebin, L. and Di Rosa, M. (1992) Br. J. Pharmacol. 107, 640-641.
5. [5] Raddassi, K., Petit, J.F. and Lemaire, G. (1993) Cell. Immunol. 195, 1134-1138.
6. [6] Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Pharmacol. Rev. 43, 109-142.
7. [7] Weisz, A., Oguchi, S., Cicatiello, L. and Esumi, H. (1994) J. Biol. Chem. 269, 8324-8333.
8. [8] Ialenti, A., Ianaro, A., Moncada, S. and Di Rosa, M. (1992) Eur. J. Pharmacol. 211, 177-182.
9. [9] Ialenti, A., Moncada, S. and Di Rosa, M. (1993) Br. J. Pharmacol. 110, 701-706.
10. [10] Iuvone, T., Carnuccio, R. and Di Rosa, M. (1994) Eur. J. Pharmacol. 256, 89-92.
11. [11] Iuvone, T., D'Acquisto, F., Van Osselar, N., Di Rosa, M., Carnuccio, R. and Herman, A.G. (1998) Br. J. Pharmacol. 123, 1325-1330.
12. [12] Xie, Q., Kashiwabara, Y. and Nathan, C. (1994) J. Biol. Chem. 269, 4705-4708.
13. [13] Baeuerle, P.A. and Henkel, T. (1994) Annu. Rev. Immunol. 12, 141-179.
14. [14] Thanos, D. and Maniatis, T. (1995) Cell 80, 529-532.
15. [15] Pang, L. and Hoult, J.R.S. (1997) Biochem. Pharm. 53, 493-500.
16. [16] Di Rosa, M., Radomski, R., Carnuccio, R. and Moncada, S. (1990) Biochem. Biophys. Res. Commun. 172, 1246-1252.
17. [17] Denizot, F. and Lang, R. (1986) J. Immunol. Methods 89, 271-275.
18. [18] D'Acquisto, F., Iuvone, T., Rombolà, L., Sautebin, L., Di Rosa, M. and Carnuccio, R. (1997) FEBS Lett. 418, 175-178.
19. [19] Di Rosa, M., Ialenti, A., Ianaro, A. and Sautebin, L. (1996) Prostaglandins Leukotrienes Essent. Fatty Acids 54, 229-238.
20. [20] Sautebin, L., Carnuccio, R., D'Acquisto, F. and Di Rosa, M. (1996) Med. Inflamm. 5, 14-17.
21. [21] Bulut, V., Severn, A. and Liew, F.Y. (1993) Biochem, Biophys. Res. Commun. 195, 1134-1138.
22. [22] Olliver, V., Parry, G.C.N., Cobb, R.R., de Prost, D. and Mackman, N. (1996) J. Biol. Chem. 271, 20828-20835.
23. [23] Coleman, R.A., Smith, W.L. and Narumiya, S. (1994) Pharmacol. Rev. 46, 205-229.
24. [24] Seldon, P.M., Barnes, P.J., Meja, K. and Giembycz, M.A. (1995) Mol. Pharmacol. 48, 747-757.
25. [25] Blaschke, V., Jungermann, K. and Puschel, G.P. (1996) FEBS Lett. 394, 39-43.